FIELD: immunology.
SUBSTANCE: isolated nucleic acid molecule encoding a T-cell receptor (hereinafter – TCR) against peptide-MHC complexes, T-cells expressing TCR, and pharmaceutical compositions are proposed. Recombinant nucleic acid encodes TCR containing (a) a beta-chain construct containing CDR1-3 with amino acid sequences SEQ ID NO: 50-52, and (b) a TCR alpha-chain construct containing CDR1-3 with amino acid sequences SEQ ID NO: 47-49. Recombinant nucleic acid and T-cells containing it are suitable for the treatment of a disease or a condition related to G12V RAS mutation.
EFFECT: inventions provide high degree of specificity and efficiency of destruction of target cells with G12V RAS mutation.
29 cl, 16 dwg, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| T-CELL RECEPTORS | 2017 |
|
RU2775623C2 |
| T-CELL RECEPTORS SPECIFIC RELATIVELY TO COMPLEX OF TUMOR ANTIGEN NY-ESO-1/HLA-A*02 | 2016 |
|
RU2775394C2 |
| SPECIFIC BINDING MOLECULES | 2020 |
|
RU2825837C2 |
| HPV-SPECIFIC BINDING MOLECULES | 2018 |
|
RU2804664C2 |
| CHIMERIC ANTIGEN RECEPTORS TARGETING VARIANT III OF EPIDERMAL GROWTH FACTOR RECEPTOR | 2017 |
|
RU2751662C2 |
| ANTI-TAU PROTEIN ANTIBODIES AND METHODS OF USING SAID ANTIBODIES | 2016 |
|
RU2732122C2 |
| NEOANTIGENS AND THEIR USE | 2019 |
|
RU2813924C2 |
| T-CELL RECEPTORS | 2018 |
|
RU2762255C2 |
| CHIMERIC ANTIGEN RECEPTOR (CAR) WITH ANTIGEN-BINDING DOMAINS TO THE T-CELL RECEPTOR β- CONSTANT REGION | 2015 |
|
RU2744046C2 |
| COMPOSITIONS AND LIBRARIES CONTAINING RECOMBINANT POLYNUCLEOTIDES ENCODING T-CELL RECEPTORS AND METHODS FOR USING RECOMBINANT T-CELL RECEPTORS | 2017 |
|
RU2752528C2 |
